Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
16.02
USD
-2.67%
Market Closed
Market Cap:
$2.4B
Income Statement
Earnings Waterfall
Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp
Income Statement
Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp
Currency: USD
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
8
|
11
|
14
|
14
|
13
|
12
|
12
|
12
|
11
|
12
|
12
|
0
|
|
| Revenue |
56
N/A
|
59
+5%
|
69
+18%
|
78
+13%
|
85
+9%
|
93
+10%
|
92
-1%
|
92
+0%
|
98
+6%
|
116
+18%
|
133
+15%
|
147
+10%
|
154
+5%
|
155
+0%
|
160
+3%
|
168
+5%
|
185
+10%
|
184
-1%
|
190
+3%
|
180
-5%
|
170
-5%
|
175
+2%
|
169
-3%
|
177
+5%
|
179
+1%
|
190
+6%
|
205
+8%
|
253
+23%
|
277
+10%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||
| Cost of Revenue |
(20)
|
(21)
|
(21)
|
(22)
|
(22)
|
(23)
|
(22)
|
(22)
|
(23)
|
(27)
|
(33)
|
(41)
|
(49)
|
(53)
|
(55)
|
(56)
|
(58)
|
(63)
|
(68)
|
(73)
|
(76)
|
(75)
|
(76)
|
(74)
|
(72)
|
(71)
|
(70)
|
(71)
|
(71)
|
|
| Gross Profit |
36
N/A
|
38
+5%
|
48
+26%
|
56
+18%
|
63
+11%
|
71
+13%
|
70
0%
|
70
0%
|
76
+8%
|
89
+17%
|
100
+13%
|
105
+5%
|
105
0%
|
102
-3%
|
105
+3%
|
112
+7%
|
127
+13%
|
121
-5%
|
122
+0%
|
107
-12%
|
95
-12%
|
100
+5%
|
92
-7%
|
104
+12%
|
107
+3%
|
119
+11%
|
136
+14%
|
182
+34%
|
206
+13%
|
|
| Operating Income | ||||||||||||||||||||||||||||||
| Operating Expenses |
(86)
|
(95)
|
(107)
|
(125)
|
(141)
|
(164)
|
(184)
|
(203)
|
(229)
|
(248)
|
(273)
|
(297)
|
(314)
|
(331)
|
(337)
|
(333)
|
(326)
|
(315)
|
(311)
|
(302)
|
(296)
|
(318)
|
(279)
|
(271)
|
(262)
|
(262)
|
(256)
|
(260)
|
(263)
|
|
| Selling, General & Administrative |
(45)
|
(50)
|
(56)
|
(63)
|
(69)
|
(80)
|
(91)
|
(100)
|
(111)
|
(121)
|
(133)
|
(152)
|
(170)
|
(184)
|
(190)
|
(187)
|
(183)
|
(177)
|
(178)
|
(176)
|
(173)
|
(171)
|
(163)
|
(161)
|
(158)
|
(156)
|
(160)
|
(163)
|
(167)
|
|
| Research & Development |
(39)
|
(43)
|
(50)
|
(61)
|
(71)
|
(82)
|
(92)
|
(101)
|
(116)
|
(126)
|
(138)
|
(143)
|
(142)
|
(141)
|
(136)
|
(130)
|
(123)
|
(119)
|
(116)
|
(111)
|
(110)
|
(109)
|
(102)
|
(99)
|
(94)
|
(88)
|
(86)
|
(85)
|
(94)
|
|
| Depreciation & Amortization |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(6)
|
(11)
|
(16)
|
(20)
|
(19)
|
(18)
|
(15)
|
(14)
|
(13)
|
(12)
|
(11)
|
(10)
|
(11)
|
(11)
|
(12)
|
(2)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
|
| Operating Income |
(50)
N/A
|
(57)
-14%
|
(59)
-5%
|
(68)
-15%
|
(78)
-15%
|
(93)
-19%
|
(114)
-22%
|
(133)
-17%
|
(153)
-15%
|
(159)
-4%
|
(172)
-8%
|
(192)
-11%
|
(209)
-9%
|
(229)
-10%
|
(232)
-1%
|
(221)
+5%
|
(199)
+10%
|
(194)
+2%
|
(190)
+2%
|
(195)
-3%
|
(202)
-3%
|
(219)
-8%
|
(185)
+15%
|
(167)
+10%
|
(155)
+7%
|
(144)
+8%
|
(122)
+15%
|
(78)
+36%
|
(57)
+27%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||
| Interest Income Expense |
3
|
4
|
4
|
7
|
10
|
11
|
12
|
9
|
7
|
4
|
3
|
2
|
2
|
1
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
2
|
3
|
5
|
4
|
3
|
1
|
(0)
|
(1)
|
(2)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
(25)
|
0
|
(33)
|
(33)
|
(7)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(46)
N/A
|
(52)
-13%
|
(56)
-6%
|
(61)
-10%
|
(69)
-12%
|
(82)
-19%
|
(101)
-24%
|
(123)
-22%
|
(146)
-18%
|
(155)
-6%
|
(169)
-9%
|
(189)
-12%
|
(207)
-9%
|
(229)
-11%
|
(232)
-1%
|
(222)
+5%
|
(200)
+10%
|
(195)
+3%
|
(191)
+2%
|
(196)
-3%
|
(225)
-15%
|
(215)
+5%
|
(213)
+1%
|
(195)
+9%
|
(160)
+18%
|
(142)
+11%
|
(121)
+14%
|
(80)
+34%
|
(59)
+26%
|
|
| Net Income | ||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
(0)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(46)
|
(52)
|
(56)
|
(61)
|
(69)
|
(82)
|
(100)
|
(122)
|
(146)
|
(155)
|
(171)
|
(191)
|
(207)
|
(229)
|
(232)
|
(222)
|
(200)
|
(195)
|
(191)
|
(196)
|
(225)
|
(215)
|
(213)
|
(195)
|
(160)
|
(142)
|
(121)
|
(80)
|
(59)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Net Income (Common) |
(46)
N/A
|
(53)
-14%
|
(56)
-7%
|
(62)
-10%
|
(70)
-12%
|
(82)
-18%
|
(100)
-21%
|
(122)
-23%
|
(146)
-20%
|
(155)
-6%
|
(171)
-10%
|
(190)
-11%
|
(207)
-9%
|
(229)
-11%
|
(232)
-1%
|
(222)
+5%
|
(200)
+10%
|
(195)
+3%
|
(191)
+2%
|
(196)
-3%
|
(225)
-15%
|
(215)
+5%
|
(213)
+1%
|
(195)
+9%
|
(159)
+18%
|
(142)
+11%
|
(121)
+14%
|
(80)
+34%
|
(59)
+26%
|
|
| EPS (Diluted) |
-0.39
N/A
|
-0.44
-13%
|
-0.47
-7%
|
-0.49
-4%
|
-0.56
-14%
|
-0.66
-18%
|
-0.78
-18%
|
-0.9
-15%
|
-1.11
-23%
|
-1.11
N/A
|
-1.21
-9%
|
-1.37
-13%
|
-1.48
-8%
|
-1.62
-9%
|
-1.64
-1%
|
-1.56
+5%
|
-1.4
+10%
|
-1.37
+2%
|
-1.33
+3%
|
-1.36
-2%
|
-1.56
-15%
|
-1.49
+4%
|
-1.47
+1%
|
-1.34
+9%
|
-1.08
+19%
|
-0.96
+11%
|
-0.82
+15%
|
-0.48
+41%
|
-0.39
+19%
|
|
Switch to:
Switch to:
See Also
Discover More
